Robert L. Simon

79 year

Health Technology

Consumer Services

Profile

Robert L.
Simon formerly worked at Bristol Myers Squibb Co., as Vice President-Worldwide Regulatory Affairs from 1987 to 2000, Gilead Sciences, Inc., as Vice President-Global Regulatory Affairs from 2000 to 2001, OSI Pharmaceuticals, Inc., as EVP-Pharmaceutical Development & Manufacturing, and Threshold Pharmaceuticals, Inc., as SVP-Regulatory Affairs & Quality Assurance.
Mr. Simon received his undergraduate degree from San Jose State University.

Former positions of Robert L. Simon

Companies	Position	End
GILEAD SCIENCES, INC.	General Counsel	2001-11-30
BRISTOL-MYERS SQUIBB COMPANY	General Counsel	2000-06-30
Threshold Pharmaceuticals, Inc. Threshold Pharmaceuticals, Inc. BiotechnologyHealth Technology Threshold Pharmaceuticals, Inc. engages in the development of therapeutics for treating tumors. It offers the Evofosfamide which designed as a prodrug that is activated under the extreme hypoxic conditions commonly found in tumors, but not typically in healthy tissues, and TH-3424 which is a small-molecule drug candidate for the treatment of liver, castrate resistant prostate cancer, T-cell acute lymphoblastic leukemias, and other cancers. The company was founded by Jeffrey W. Bird on October 17, 2001 and is headquartered in South San Francisco, CA	General Counsel	-
OSI PHARMACEUTICALS, INC.	Corporate Officer/Principal	-

See the detail of Robert L. Simon's experience

Training of Robert L. Simon

San Jose State University

Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Robert L. Simon's experience

Connections

100 +

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	2
GILEAD SCIENCES, INC.	Health Technology
BRISTOL-MYERS SQUIBB COMPANY	Health Technology

Private companies	2
OSI Pharmaceuticals, Inc. OSI Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology OSI Pharmaceuticals, Inc. manufactured and develope dpharmaceutical drugs. The company was founded in 1983 and was headquartered in Farmingdale, NY.	Health Technology
Threshold Pharmaceuticals, Inc. Threshold Pharmaceuticals, Inc. BiotechnologyHealth Technology Threshold Pharmaceuticals, Inc. engages in the development of therapeutics for treating tumors. It offers the Evofosfamide which designed as a prodrug that is activated under the extreme hypoxic conditions commonly found in tumors, but not typically in healthy tissues, and TH-3424 which is a small-molecule drug candidate for the treatment of liver, castrate resistant prostate cancer, T-cell acute lymphoblastic leukemias, and other cancers. The company was founded by Jeffrey W. Bird on October 17, 2001 and is headquartered in South San Francisco, CA	Health Technology